Brief: Revelation Biosciences Commences First In Human Phase 1 Clinical Study Of Gemini

Revelation Biosciences

04/03/2024 14:29

March 4 (Reuters) - Revelation Biosciences Inc  REVB.O :
    * REVELATION BIOSCIENCES INC. ANNOUNCES COMMENCEMENT OF
FIRST IN
HUMAN PHASE 1 CLINICAL STUDY OF GEMINI
    * REVELATION BIOSCIENCES INC - TOP-LINE DATA INCLUDING
SAFETY,
TOLERABILITY, AND BIOMARKER ACTIVITY ANTICIPATED THIS SUMMER

Source text for Eikon:  ID:nBw8x1TPqa 
Further company coverage:  REVB.O 

 ((Reuters.Briefs@thomsonreuters.com;))